BLUEPRINT MEDICINES CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 93 USD | +2.50% |
|
+7.08% | +0.82% |
| 04-25 | Transcript : Blueprint Medicines Corporation - Special Call | |
| 03-22 | Blueprint Medicines Insider Sold Shares Worth $2,188,265, According to a Recent SEC Filing | MT |
Chart calendar Blueprint Medicines Corporation
32.4a8YgkyfnwoiyjWh211koPL2nrgSL_SBMTHKmKwX5Ls.rvwo6n_I62Z9vWTmlDVdk6is9dpxSJf5Yl3zzOZngN-r3VnpCffFSEGgdA~d19bef9483d4f8157f67e265068c3600
Upcoming events on Blueprint Medicines Corporation
Past events on Blueprint Medicines Corporation
| 25/04/2024 15:00 | Business Update Call |
| 04/03/2024 14:10 | TD Cowen Health Care Conference |
| 25/02/2024 21:45 | American Academy of Allergy, Asthma & Immunology Meeting - Abstract No - 783 |
| 25/02/2024 19:25 | American Academy of Allergy, Asthma & Immunology Meeting - Abstract No - 739 |
| 25/02/2024 19:15 | American Academy of Allergy, Asthma & Immunology Meeting - Abstract No - 737 |
| 25/02/2024 14:45 | American Academy of Allergy, Asthma & Immunology Meeting - Abstract No - 691 |
| 25/02/2024 14:45 | American Academy of Allergy, Asthma & Immunology Meeting - Abstract No - 692 |
| 25/02/2024 14:45 | American Academy of Allergy, Asthma & Immunology Meeting - Abstract No - 696 |
| 25/02/2024 14:45 | American Academy of Allergy, Asthma & Immunology Meeting - Abstract No - 693 |
| 25/02/2024 14:45 | American Academy of Allergy, Asthma & Immunology Meeting - Abstract No - 689 |
| 23/02/2024 20:15 | American Academy of Allergy Asthma & Immunology Meeting - Abstract No - 189 |
| 15/02/2024 13:00 | Q4 2023 Earnings Call |
| 15/02/2024 12:00 | Q4 2023 Earnings Release |
| 08/01/2024 18:30 | JPMorgan Healthcare Conference |
| 10/12/2023 14:00 | American Society of Hematology Meeting - Abstract No: 3800 |
| 09/12/2023 18:15 | American Society of Hematology Meeting - Abstract No: 76 |
| 09/12/2023 18:00 | American Society of Hematology Meeting - Abstract No: 75 |
| 08/12/2023 | American Society of Hematology Meeting - Abstract No: 6406 |
| 05/12/2023 16:00 | JMP Securities Hematology and Oncology Summit |
| 15/11/2023 17:40 | Stifel Healthcare Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 66,5 41,4 60.62% | 794 789 0.62% | 180 177 2.01% | 204 199 2.78% | 249 245 1.79% | 393 |
|
EBITDA Million USD | Released Forecast Spread | -356 -350 -1.72% | 315 327 -3.49% | -636 -430 -47.7% | -526 -535 1.68% | -475 -498 4.62% | -342 |
|
EBIT Million USD | Released Forecast Spread | -361 -374 3.33% | 309 252 22.59% | -642 -428 -49.91% | -538 -544 1.15% | -486 -501 2.95% | -313 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -348 -364 4.55% | 315 313 0.76% | -641 -423 -51.41% | -552 -552 -0.03% | -506 -519 2.55% | -343 |
|
Net income Million USD | Released Forecast Spread | -348 -366 5.02% | 314 311 0.91% | -644 -413 -55.85% | -558 -559 0.21% | -507 -520 2.47% | -340 |
|
EPS USD | Released Forecast Spread | -7,27 -7,71 5.68% | 5,59 5,48 1.98% | -11,0 -7,04 -56.47% | -9,35 -9,35 -0.01% | -8,37 -8,58 2.45% | -5,54 |
| Announcement Date | 13/02/20 | 17/02/21 | 16/02/22 | 16/02/23 | 15/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 107 104 2.76% | 62,7 40,0 56.89% | 36,5 37,6 -2.83% | 66,0 43,9 50.37% | 38,8 33,5 15.69% | 63,3 41,9 51.21% | 57,6 45,6 26.24% | 56,6 50,7 11.68% | 72,0 67,1 7.23% | 81,4 | 93,1 | 104 | 116 | 121 |
|
EBITDA Million USD | Released Forecast Spread | -314 -52,0 -504.75% | -104 -103 -1.17% | -156 -129 -21.06% | -123 -155 20.91% | -143 -151 5.44% | -121 -172 29.93% | -124 -155 19.74% | -126 -163 22.63% | -104 -117 11.47% | -95,0 | -89,0 | -83,0 | -81,0 | -61,0 |
|
EBIT Million USD | Released Forecast Spread | -316 -96,5 -227.5% | -106 -115 7.87% | -158 -133 -18.73% | -124 -150 16.96% | -150 -156 4.05% | -124 -157 20.65% | -128 -150 14.69% | -129 -140 7.61% | -105 -119 11.83% | -94,7 | -83,5 | -71,1 | -59,8 | -62,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -316 -74,4 -324.82% | -106 -114 7.21% | -157 -130 -20.8% | -132 -150 11.59% | -158 -158 0.09% | -129 -160 19.49% | -133 -154 13.87% | -134 -146 8.47% | -111 -124 10.4% | -101 | -91,0 | -79,9 | -70,2 | -72,6 |
|
Net income Million USD | Released Forecast Spread | -319 -67,7 -370.41% | -106 -112 5.52% | -160 -132 -21.34% | -133 -151 11.58% | -159 -160 1.06% | -130 -161 19.4% | -133 -153 13.3% | -134 -145 7.81% | -111 -125 11% | -101 | -90,0 | -79,4 | -69,7 | -68,7 |
|
EPS USD | Released Forecast Spread | -5,40 -1,15 -370.38% | -1,79 -1,89 5.15% | -2,68 -2,23 -20.35% | -2,23 -2,51 11.29% | -2,65 -2,67 0.64% | -2,15 -2,66 19.2% | -2,19 -2,53 13.56% | -2,20 -2,39 7.76% | -1,82 -2,04 10.88% | -1,65 | -1,46 | -1,28 | -1,10 | -1,06 |
| Announcement Date | 16/02/22 | 03/05/22 | 02/08/22 | 01/11/22 | 16/02/23 | 04/05/23 | 02/08/23 | 26/10/23 | 15/02/24 | - | - | - | - | - |
More events
Past sector events for Blueprint Medicines Corporation
| 26/04/2024 | GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release |
| 26/04/2024 | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 06:00 | BB BIOTECH AG: Q1 2024 Earnings Release |
| 25/04/2024 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 25/04/2024 | PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release |
| 25/04/2024 | HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected) |
| 25/04/2024 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release |
| 25/04/2024 | CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 25/04/2024 12:00 | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release |
| 25/04/2024 07:00 | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- BPMC Stock
- Calendar Blueprint Medicines Corporation
